Although its role in NTM infection remains unclear, studies have shown that FGB is dysregulated in various diseases, such as renal cell carcinoma, malignant pulmonary nodules, and breast cancer, and is associated with disease progression [16–18]. This evidence concerns the gene FGB and breast cancer.